Tag: class actions
Major drug manufacturers and distributors suspected of colluding to inflate profits at consumers’ expense
Several drug manufacturers, suppliers and pharmacy benefit managers have reportedly been caught colluding to fix prices for insulin.
In what’s believed to be efforts to allegedly inflate profits, companies reportedly worked together to set consistently high prices for the drugs. This way, no matter where consumers purchased their insulin from, they’d be paying high prices. By price-fixing, no company undercuts the other by offering a cheaper price, which is anti-competitive behaviour that can be extremely harmful for competition and for the consumer.
These are the accusations being brought by those bringing a legal action.
Continue Reading…
Amazon must provide their customers’ personal information in WEN lawsuit
In a recent lawsuit against WEN, Federal Judge James Robert has ordered Amazon to provide a list of customers who bought WEN hair-care products from them to assist in the class-action lawsuit where many consumers documented hair loss and other hair-related problems after using the product.
The WEN-lawsuit is believed to involve over 200 women from 40 different states in the U.S. and we are investigating issues here in the U.K. too. According to the lawsuit, the women claim that:
“WEN products can cause severe and possibly permanent damage to hair, including significant hair loss to the point of visible bald spots, hair breakage, scalp irritation and rash.”
Caterpillar’s £47 million settlement for a defect in heavy-duty engines
The Caterpillar Inc. class-action lawsuit reportedly produced favourable results for affected vehicle owners. Recently, a New Jersey judge approved a £47 million settlement to compensate owners for the alleged defects in their heavy-duty diesel engines.
The case, which has been litigated since 2012, recently came to a close when Judge Jerome Simandle of the U.S. District Court for the District of New Jersey approved the £47 million settlement offer.
Continue Reading…
Sanofi Depakote epilepsy drug that reportedly caused birth defects in 10,000 unborn babies
Valproate Semisodium, better known as Depakote, has reportedly put more than 10,000 pregnant women at risk in France, and there are raising concerns that the same amount of women in the U.K. may also be affected by the epilepsy drug.
Our Group Action Lawyers are investigating the issues, and anyone affected here in the U.K. is free to come forward for confidential and no obligation advice.
Continue Reading…